UMIN000048977
Lung Cancer Genomic Screening Project for Neoadjuvant and Adjuvant setting Molecular Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer and the Assessment of monitoring Minimal Residual Disease
National Cancer Center·Not Applicable·University Hospital Medical Information NetworkEnrolling by invitation
Study focus
- Disease/Condition
- Lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- National Cancer Center
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Aug 29, 2022
- End date
- N/A
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048977
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048977 through Pure Global AI's free database. This Not Applicable trial is sponsored by National Cancer Center and is currently Enrolling by invitation. The study focuses on Lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.